OrbiMed’s K2M Group Holdings, Inc KTWO Stock Holding History

OrbiMed’s Portfolio KTWO Stock Details KTWO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-843,205	Closed	-$19M	–	167
2018 Q2	$19M	Hold	843,205	–	–	0.23%	96
2018 Q1	$16M	Buy	+843,205	New	+$16.7M	0.2%	88

Other funds holding KTWO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

OrbiMed's KTWO Position: Q3 2018 in Review

OrbiMed sold out of K2M Group Holdings, Inc (KTWO) in Q3 2018, closing a stake of 843,205 shares — an estimated $19M sold.

OrbiMed first reported a position in KTWO in Q1 2018 and held it in 2 quarters. The position peaked at $19M in Q2 2018. 153 funds tracked by Wall St. Rank hold KTWO as of Q3 2018.

OrbiMed reported no remaining K2M Group Holdings, Inc position as of Q3 2018 after selling out during the quarter.
OrbiMed sold 843,205 K2M Group Holdings, Inc shares in Q3 2018, an estimated $19M.
OrbiMed first reported a position in K2M Group Holdings, Inc in Q1 2018 and held it in 2 quarters.
OrbiMed's K2M Group Holdings, Inc position peaked at $19M in Q2 2018.
153 funds tracked by Wall St. Rank held K2M Group Holdings, Inc as of Q3 2018.

Based on OrbiMed's 13F filing for Q3 2018, filed 14 Nov 2018.